The Drug Enforcement Administration needs better tools for ensuring that registrants who are at risk of illicit diversion are identified and remain eligible to handle or prescribe controlled substances, the Government Accountability Office said in a May report to congressional requesters. In its report, DEA Should Take Additional Actions to Reduce Risks in Monitoring the Continued... Read More